<DOC>
	<DOCNO>NCT02664207</DOCNO>
	<brief_summary>The purpose study offer pre-natal Myelomeningocele ( MMC ) repair surgery mother BMI 35-40 kg/m2 ( extend Management Myelomeningocele Study ( MOMs ) criteria BMI ) evaluate efficacy safety extension , capture clinical outcome information .</brief_summary>
	<brief_title>Extended Criteria For Fetal Myelomeningocele Repair</brief_title>
	<detailed_description />
	<mesh_term>Meningomyelocele</mesh_term>
	<mesh_term>Spina Bifida Cystica</mesh_term>
	<criteria>Any woman prenatal diagnosis myelomeningocele . Prepregnancy BMI 3540 kg/m2 . MOMs Trial inclusion criterion ( exception BMI ) poor glycemic control ( i.e. , HbA1c â‰¥ 8 % ) spite medical antidiabetic therapy accordance good clinical practice ( GCP ) presence significant comorbidities complication ( dyslipidemia , uncontrolled arterial hypertension , impaired renal function , neuropathy , retinopathy , CVD ) severe diabetes complication associate medical condition ( blindness , endstage renal failure , liver cirrhosis , malignancy , chronic congestive heart failure ) recent ( within precede 12 month ) myocardial infarction , stroke TIA unstable angina pectoris MOMs Trial exclusion criterion ( exception BMI )</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Myelomeningocele repair</keyword>
	<keyword>Open Neural Tube Defect</keyword>
	<keyword>BMI 35-40 kg/m2 ,</keyword>
	<keyword>Open Fetal Surgery</keyword>
	<keyword>Elevated body mass index</keyword>
</DOC>